Nickel Silicide Formation Using Excimer Laser Annealing

AbstractIn this work, we report on a self-aligned nickel silicide formation technique based on excimer laser annealing (ELA). We evaluate this process for the front contact formation of industrial PERC type solar cells on random pyramid textured Si surfaces where damage to surface texture, emitter passivation, or to the shallow junction should be avoided or minimized. PERC type solar cells obtained by POCl3 diffusion were processed on large area (12.5x12.5cm2) CZ-Si. Self-aligned litho-free Ni/Cu contacts defined by ps-laser ablation of the SiO2/SiNx anti-reflective coating (ARC) and subsequent ELA of the Ni layer were compared to conventional Ag screen printed contacts.The novel ELA process results in an absolute gain in Jsc of 0.8mA/cm2 as well as a drop of 0.3Ω.cm2 in series resistance (Rs) compared to SP Ag contacts due to reduced shading and resistance losses. This leads to 0.5% absolute increase in efficiency from 19.3% to 19.7% since other characteristics (Voc, pFF) could be maintained to the same level. In this work, the best performing cell with the ELA process reached an outstanding 20.0% energy conversion efficiency with Jsc=39.3mA/cm2, Voc=649.8mV, and FF=78.3%

Genotypic to Phenotypic Resistance Discrepancies Identified Involving β-Lactamase Genes, blaKPC, blaIMP, blaNDM-1, and blaVIM in Uropathogenic Klebsiella pneumoniae

Introduction: Klebsiella pneumoniae carbapenemase (KPC) belongs to the Group-A β-lactamases that incorporate serine at their active site and hydrolyze various penicillins, cephalosporins, and carbapenems. Metallo-beta-lactamases (MBLs) are group-B enzymes that contain one or two essential zinc ions in the active sites and hydrolyze almost all clinically available β-lactam antibiotics. Klebsiella pneumoniae remains the pathogen with the most antimicrobial resistance to KPC and MBLs. Methods: This research investigated the blaKPC, and MBL genes, namely, blaIMP, blaVIM, and blaNDM-1 and their phenotypic resistance to K. pneumoniae isolated from urinary tract infections (UTI) in Bangladesh. Isolated UTI K. pneumoniae were identified by API-20E and 16s rDNA gene analysis. Their phenotypic antimicrobial resistance was examined by the Kirby-Bauer disc diffusion method, followed by minimal inhibitory concentration (MIC) determination. blaKPC, blaIMP, blaNDM-1, and blaVIM genes were evaluated by polymerase chain reactions (PCR) and confirmed by sequencing. Results: Fifty-eight K. pneumoniae were identified from 142 acute UTI cases. Their phenotypic resistance to amoxycillin-clavulanic acid, cephalexin, cefuroxime, ceftriaxone, and imipenem were 98.3%, 100%, 96.5%, 91.4%, 75.1%, respectively. Over half (31/58) of the isolates contained either blaKPC or one of the MBL genes. Individual prevalence of blaKPC, blaIMP, blaNDM-1, and blaVIM were 15.5% (9), 10.3% (6), 22.4% (13), and 19% (11), respectively. Of these, eight isolates (25.8%, 8/31) were found to have two genes in four different combinations. The co-existence of the ESBL genes generated more resistance than each one individually. Some isolates appeared phenotypically susceptible to imipenem in the presence of blaKPC, blaIMP, blaVIM, and blaNDM-1 genes, singly or in combination. Conclusion: The discrepancy of genotype and phenotype resistance has significant consequences for clinical bacteriology, precision in diagnosis, the prudent selection of antimicrobials, and rational prescribing. Heterogeneous phenotypes of antimicrobial susceptibility testing should be taken seriously to avoid inappropriate diagnostic and therapeutic decisions

Etude et modelisation d'un generateur photovoltaieque a forte concentration pour cellules au silicium. Contribution a la caracterisation in situ des cellules solaires a concentration

SIGLEINIST T 70879 / INIST-CNRS - Institut de l'Information Scientifique et TechniqueFRFranc

Quid du clonage dans les compétitions de chevaux

Le 7 décembre dernier, le n°1 mondial de polo Adolfo Cambiasso a gagné la plus importante compétition internationale qui existe depuis 1893 : le championnat d’Argentine open. L’originalité de cette victoire repose sur « Show me », la jument montée par Adolfo: une jument clonée. En l’occurrence, l'équidé a été monté moins de 5 minutes sur un match d'une durée totale de 2 heures. Le polo est géré par la Fédération Française de Polo (FFP) et son alter égo la Fédération Internationale de Polo (FIP). Les autres disciplines équines sont visées par la Fédération Française d’Equitation (FFE) et la Fédération Internationale d’Equitation (FEI). Le clonage autorisé depuis 2012 par la FEI

Emergence of New Non–Clonal Group 258 High-Risk Clones among Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Isolates, France

International audienceThe worldwide spread of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) isolates was reported to be caused by dissemination of 1 clonal complex (i.e., clonal group [CG] 258, which includes sequence types [STs] 258 and 512). We conducted whole-genome sequencing and epidemiologic analysis of all KPC-Kp isolates in France in 2018 and found that new successful high-risk clones of ST147, ST307, ST231, and ST383 are now the main drivers of blaKPC genes. The blaKPC genes were mostly carried by Tn4401a and Tn4401d structures and a new non-Tn4401 element. Our epidemiologic investigations showed that the emergence of these non-CG258 KPC-Kp isolates in France was linked to dissemination of these clones from Portugal. Thus, KPC-Kp epidemiology has changed in Europe, at least in several non-KPC-endemic countries of western Europe, such as France and Portugal, where CG258 is not the most prevalent clone

KPC-39-mediated resistance to Ceftazidime-Avibactam in a Klebsiella pneumoniae ST307 clinical isolate

International audienceResistance to ceftazidime–avibactam (CAZ-AVI) combination is being increasingly reported. Here, we report a CAZ-AVI resistant Klebsiella pneumoniae belonging to the high-risk ST307 clone and producing KPC-39, a single amino-acid variant of KPC-3 (A172T). Cloning experiments, steady state kinetic parameters and molecular dynamics simulations revealed a loss of carbapenemase activity and an increased affinity for ceftazidime. KPC-39 was identified in a patient without prior exposure to CAZ-AVI, suggesting silent dissemination in European healthcare settings